STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
Stat News • 5/28/2026 – 5/30/2026
Summary
No summary yet.
Advertisement
Cluster Activity
1
1
2026-05-282026-05-29
Lindy Score Breakdown (V4.2)
11h
Age
1
Sources
from cluster
1
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier99% (0.5^1/48)
Hero EligibleYes
Story Timeline
- 2026-05-28
- 2026-05-29STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer (current)
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Same Story from 2 sources
Breaking Similar stories
STAT+: An ASCO preview: What to watch for at cancer research’s big meeting
Stat News • 1 day ago
STAT+: Ahead of ASCO, all eyes on pancreatic cancer
Stat News • 1 day ago
STAT+: Experimental hepatitis B treatment was a ‘functional cure’ for nearly 1 in 5, new data show
Stat News • 2 days ago
STAT+: Allogene CEO David Chang stepping down
Stat News • Today
STAT+: Trump administration seeks to overhaul federal grantmaking process, alarming researchers
Stat News • Today
STAT+: Massachusetts sues UnitedHealth, alleging fraud in state’s Medicaid plans for seniors
Stat News • Today
STAT+: Biotech veteran Jeremy Levin on why the industry’s future is secure, but American leadership is at risk
Stat News • 1 day ago
STAT+: Where patients and hospitals disagree about AI
Stat News • 2 days ago
STAT+: Up and down the ladder: The latest comings and goings
Stat News • Today
STAT+: The woman behind the world’s biggest longevity competition
Stat News • 1 day ago